Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

China NMPA grants conditional approval to toripalimab in nasopharyngeal carcinoma

Feb. 22, 2021

FDA approves label expansion in chronic heart failure for Entresto

Feb. 17, 2021

TLX-591-CDx for prostate cancer imaging receives first E.U. approval in Czech Republic

Feb. 16, 2021

Panzyga approved in U.S. for chronic inflammatory demyelinating polyneuropathy

Feb. 15, 2021

FDA approves Cosela for myeloprotection in patients with extensive-stage SCLC receiving chemotherapy

Feb. 15, 2021

Spanish AEMPS approves CAR-T ARI-0001 for ALL

Feb. 12, 2021

FDA approves Evkeeza for homozygous familial hypercholesterolemia

Feb. 12, 2021

FDA grants EUA for etesevimab and bamlanivimab for mild to moderate COVID-19

Feb. 10, 2021

FDA approves Libtayo for advanced basal cell carcinoma

Feb. 10, 2021

FDA approves Breyanzi for relapsed or refractory large B-cell lymphoma

Feb. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...